Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.
Investing.com - Guggenheim has reiterated its Buy rating on AstraZeneca (NASDAQ:AZN) (AZN:LN) with a price target of ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
Zacks.com on MSN
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note
Astrazeneca (AZN) closed the most recent trading day at $96.34, moving +1.94% from the previous trading session.
New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.
A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General ...
4hon MSN
N.Y. Attorney General Sues Former Emergent Biosolutions CEO for Insider Trading -- 2nd Update
New York Attorney General Letitia James filed suit against the former head of Emergent BioSolutions, accusing him of insider trading for selling his shares in the company before disclosing ...
Get insights on the stock outlook for ITC, Canara Bank, Power Grid, and AstraZeneca Pharma with expert analysis.
AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...
Investing.com - Raymond James has reiterated an Outperform rating on Walmart (NASDAQ:WMT) stock with a price target of ...
Tempus AI stock remains in a bear market after crashing by 36% from its highest point in September last year. What next for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback